Paraneoplastic Retinopathies and Optic Neuropathies

Aaronson, 1995, Non-neuronal enolase is an endothelial hypoxic stress protein, J Biol Chem, 270, 27752, 10.1074/jbc.270.46.27752 Adamus, 1996, Epitope recognition of recoverin in cancer associated retinopathy, J Neurosci Res, 45, 863, 10.1002/(SICI)1097-4547(19960915)45:6<863::AID-JNR23>3.0.CO;2-V Adamus, 1998, Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy, Arch Ophthalmol, 116, 251 Adamus, 1993, Anti-enolase anti bodies in cancer- associated retinopathy, Invest Ophthalmol Vis Sci, 34, 1485 Adamus, 1993, Role of anti-recoverin autoantibodies in cancer-associated retinopathy, Invest Ophthalmol Vis Sci, 34, 2626 Adamus, 1998, Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo, J Autoimmun, 11, 523, 10.1006/jaut.1998.0221 Adamus, 1997, Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy, Invest Ophthalmol Vis Sci, 38, 283 Akhmedov, 2000, A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse, Proc Natl Acad Sci USA, 97, 5551, 10.1073/pnas.97.10.5551 Akoun, 1985, Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer, Chest, 87, 39, 10.1378/chest.87.1.39 Alexander, 1992, On response defect in paraneoplastic night blindness with cutaneous malignant melanoma, Invest Ophthalmol Vis Sci, 33, 477 Alexianu, 1994, Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis, J Neurochem, 63, 2365, 10.1046/j.1471-4159.1994.63062365.x Andreasson, 1993, Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy, Acta Ophthalmol (Copenh), 71, 487, 10.1111/j.1755-3768.1993.tb04623.x Antoine, 2001, Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy, Ann Neurol, 49, 214, 10.1002/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W Berson, 1988, Paraneoplastic night blindness with malignant melanoma, Am J Ophthalmol, 106, 307, 10.1016/0002-9394(88)90366-2 Blumenthal, 1998, Small-cell carcinoma of the lung presenting with paraneoplastic peripheral nerve microvasculitis and optic neuropathy, Muscle Nerve, 21, 1358, 10.1002/(SICI)1097-4598(199810)21:10<1358::AID-MUS25>3.0.CO;2-X Boeck, 1997, Melanoma-associated paraneoplastic retinopathy, Br J Dermatol, 137, 457, 10.1111/j.1365-2133.1997.tb03759.x Boghen, 1988, Paraneoplastic optic neuritis and encephalomyelitis. Report of a case, Arch Neurol, 45, 353, 10.1001/archneur.1988.00520270135034 Borkowski, 2001, Retinal findings in melanoma-associated retinopathy, Am J Ophthalmol, 132, 273, 10.1016/S0002-9394(01)00915-1 Boucher, 1997, Cancer-associated retinopathy, Can J Ophthalmol, 32, 46 Bret-Dibat, 1996, Melanoma-associated retinopathy. Apropos of a case and review of the literature, Bull Cancer, 83, 1019 Brink, 1997, Unusual retinal pigment epitheliopathy and choroidopathy in carcinomatosis, Graefes Arch Clin Exp Ophthalmol, 236, 75, 10.1007/PL00012735 Buchanan, 1984, An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma, Am J Ophthalmol, 97, 277, 10.1016/0002-9394(84)90623-8 Campo, 1992, Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome, Cancer, 69, 2283, 10.1002/1097-0142(19920501)69:9<2283::AID-CNCR2820690913>3.0.CO;2-V Carney, 1982, Serum neuron-specific enolase, Lancet, 1, 583, 10.1016/S0140-6736(82)91748-2 Chant, 1985, Autoimmunity in hereditary retinal degeneration. I. Basic studies, Br J Ophthalmol, 69, 19, 10.1136/bjo.69.1.19 Chen, 1999, Retina-specific nuclear receptor, Proc Natl Acad Sci USA, 96, 15149, 10.1073/pnas.96.26.15149 Chen, 2001, In vitro inhibition of antirecoverin immunoglobulin-mediated death of mammalian photoreceptor cells, J Neurosci Res, 63, 116, 10.1002/1097-4547(20010115)63:2<116::AID-JNR1003>3.0.CO;2-G Cogan DG, Kuwabara T, Currie J, Kattah J: [Paraneoplastic retinopathy simulating cone dystrophy with achromatopsia]. Klin Monatsbl Augenheilkd 197:156–8, 1990 Coppeto, 1988, Optic neuropathy associated with chronic lymphomatous meningitis, J Clin Neuroophthalmol, 8, 39 Crofts, 1988, Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma, Can J Ophthalmol, 23, 128 de la Sayette, 1998, Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies, Arch Neurol, 55, 405, 10.1001/archneur.55.3.405 DuBois, 1988, Inner retinal layer loss in complicated migraine. Case report, Arch Ophthalmol, 106, 1035, 10.1001/archopht.1988.01060140187016 Eichen, 2001, The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy, J Neuroophthalmol, 21, 168, 10.1097/00041327-200109000-00003 Eltabbakh, 1995, Paraneoplastic retinopathy associated with uterine sarcoma, Gynecol Oncol, 58, 120, 10.1006/gyno.1995.1194 Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939 Feigl, 2000, Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/Isotretinoin therapy in cutaneous malignant melanoma, Ophthalmologica, 214, 271, 10.1159/000027503 Fernandez, 1995, Oxygen radical production and thiol depletion are required for Ca(2+)-mediated endogenous endonuclease activation in apoptotic thymocytes, J Immunol, 155, 5133 Flynn, 2000, Antiretinal Müller cell antibodies in patients with melanoma associated and autoimmune retinopathy, Invest Ophthalmol Vis Sci, 41, 567 Garrigues, 1986, The melanoma proteoglycan, J Cell Biol, 103, 1699, 10.1083/jcb.103.5.1699 Gass JDM: Acute Vogt-Koyanagi-Harada-like syndrome occurring in a patient with metastatic cutaneous melanoma, in Saari KM (ed): Uveitis Update: Proceedings of the First International Symposium on Uveitis, 1984 May 16–19; Hanasaari, Espoo, Finland. Amsterdam, Elsevier Science, 1984, pp 407–8 Gehrs, 1992, Hemeralopia in an older adult, Surv Ophthalmol, 37, 185, 10.1016/0039-6257(92)90136-H Gittinger, 1999, Cutaneous melanoma-associated paraneoplastic retinopathy, Am J Ophthalmol, 127, 612, 10.1016/S0002-9394(98)00431-0 Grunwald, 1985, Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma, Lancet, 1, 658, 10.1016/S0140-6736(85)91326-1 Grunwald, 1987, Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells, Cancer, 60, 780, 10.1002/1097-0142(19870815)60:4<780::AID-CNCR2820600413>3.0.CO;2-9 Guy, 1999, Treatment of paraneoplastic visual loss with intravenous immunoglobulin, Arch Ophthalmol, 117, 471, 10.1001/archopht.117.4.471 Haider, 2000, Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate, Nat Genet, 24, 127, 10.1038/72777 Harmon, 1999, Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma, Gynecol Oncol, 73, 430, 10.1006/gyno.1999.5342 Haus, 2000, Ocular findings in 28 patients with cutaneous malignant melanoma (CMM), Invest Ophthalmol Vis Sci, 41, 568 Heckenlively, 2000, Autoimmune retinopathy, Arch Ophthalmol, 118, 1525, 10.1001/archopht.118.11.1525 Heckenlively, 1985, Autoimmunity in hereditary retinal degenerations. II. Clinical studies, Br J Ophthalmol, 69, 758, 10.1136/bjo.69.10.758 Hoh, 1991, Paraneoplastic optic neuropathy in nasopharyngeal carcinoma—report of a case, Singapore Med J, 32, 170 Holder, 2000, Electrophysiological features of melanoma associated retinopathy (MAR), Invest Opthhalmol Vis Sci, 41, 568 Hollemann, 1998, The Xenopus homologue of the Drosophila gene tailless has a function in early eye development, Development, 125, 2425, 10.1242/dev.125.13.2425 Honnorat, 1996, Antibodies to a subpopulation of glial cells and 166 kDa developmental protein in patients with paraneoplastic neurological syndromes, J Neurol Neurosurg Psychiatry, 6, 270, 10.1136/jnnp.61.3.270 Ing, 1996, Lung cancer with visual loss, Surv Ophthalmol, 40, 505, 10.1016/S0039-6257(96)82017-0 Ishiguro, 1982, High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma, Clin Chim Acta, 121, 173, 10.1016/0009-8981(82)90056-0 Jacobson DM: Paraneoplastic diseases of neuro-ophthalmologic interest, in Miller NR, Newman N (eds): Walsh & Hoyts Clinical Neuro-Ophthalmology. Baltimore: Williams and Wilkins, 1998, ed 5, pp 2497–51 Jacobson, 2001, Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma, Am J Ophthalmol, 131, 806, 10.1016/S0002-9394(00)00925-9 Jacobson, 1995, Paraneoplastic cone dysfunction, Arch Ophthalmol, 113, 1580, 10.1001/archopht.1995.01100120112032 Jacobson, 1990, A clinical triad to diagnose paraneoplastic retinopathy, Ann Neurol, 28, 162, 10.1002/ana.410280208 Jacobson, 1990, SWS (blue) cone hypersensitivity in a newly identified retinal degeneration, Invest Ophthalmol Vis Sci, 31, 827 Kashiwabara, 1999, Cancer-associated retinopathy during treatment for small-cell lung carcinoma, Intern Med, 38, 597, 10.2169/internalmedicine.38.597 Kawamura, 1994, Inhibition of rhodopsin phosphorylation by non-myristoylated recombinant recoverin, Biochem Biophys Res Commun, 203, 121, 10.1006/bbrc.1994.2157 Kellner, 1995, Severe course of cutaneous melanoma associated paraneoplastic retinopathy, Br J Ophthalmol, 79, 746, 10.1136/bjo.79.8.746 Kellner, 1994, Severe course of cutaneous melanoma associated retinopathy, Invest Ophthalmol Vis Sci, 35, 2117 Keltner, 1983, Photoreceptor degeneration. Possible autoimmune disorder, Arch Ophthalmol, 101, 564, 10.1001/archopht.1983.01040010564006 Keltner, 1999, The 22-kDa antigen in optic nerve and retinal diseases, J Neuroophthalmol, 19, 71, 10.1097/00041327-199906000-00001 Keltner, 1998, Cancer-associated retinopathy vs recoverin-associated retinopathy, Am J Ophthalmol, 126, 296 Keltner, 1992, Management and monitoring of cancer-associated retinopathy, Arch Ophthalmol, 110, 48, 10.1001/archopht.1992.01080130050025 Keltner, 2001, Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome, J Neuroophthalmol, 21, 173, 10.1097/00041327-200109000-00004 Kennedy, 1987, Paraneoplastic papilloedema in neuroblastoma, Postgrad Med J, 63, 873, 10.1136/pgmj.63.744.873 Kikuchi, 2000, Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy, J Neuroimmunol, 103, 26, 10.1016/S0165-5728(99)00163-0 Kim, 1994, Cutaneous melanoma-associated retinopathy, Ophthalmology, 101, 1837, 10.1016/S0161-6420(94)31092-X Kiratli, 1997, Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site, Eye, 11, 889, 10.1038/eye.1997.227 Klingele, 1984, Paraneoplastic retinopathy, J Clin Neuroophthalmol, 4, 239 Kobayashi, 1999, Identification of a photoreceptor cell-specific nuclear receptor, Proc Natl Acad Sci USA, 96, 4814, 10.1073/pnas.96.9.4814 Kornguth, 1986, Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome, Cancer Res, 46, 2588 Kornguth, 1982, Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung, Cancer, 50, 1289, 10.1002/1097-0142(19821001)50:7<1289::AID-CNCR2820500711>3.0.CO;2-9 Lambrecht, 1987, Retrobulbar neuritis as the first sign of the glucagonoma syndrome, Int Ophthalmol, 11, 13, 10.1007/BF02027892 Lei, 2000, Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo, Invest Ophthalmol Vis Sci, 41, 262 Livingston, 1994, Improved survival in stage III melanoma patients with GM2 antibodies, J Clin Oncol, 12, 1036, 10.1200/JCO.1994.12.5.1036 Luiz, 1998, Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung, J Neuroophthalmol, 18, 178, 10.1097/00041327-199809000-00006 MacKay, 1994, Paraneoplastic cone dystrophy, Invest Ophthalmol Vis Sci, 35, 2119 MacKay, 1992, S-cone and rod ERG's reduced in paraneoplastic retinal degeneration, Invest Ophthalmol Vis Sci, 33, 1074 Maeda, 2001, Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome, Eur J Immunol, 31, 563, 10.1002/1521-4141(200102)31:2<563::AID-IMMU563>3.0.CO;2-D Maeda, 2001, Mechanisms of photoreceptor cell death in cancer-associated retinopathy, Invest Ophthalmol Vis Sci, 42, 705 Malik, 1992, Optic neuropathy, J Clin Neuroophthalmol, 12, 137 Marmor, 1990, Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity, Am J Ophthalmol, 110, 124, 10.1016/S0002-9394(14)76980-6 Masaoka, 1999, Fluorescein angiographic findings in a case of cancer-associated retinopathy, Retina, 19, 462, 10.1097/00006982-199919050-00022 Matsui, 1992, Electrophysiological findings in paraneoplastic retinopathy, Graefes Arch Clin Exp Ophthalmol, 230, 324, 10.1007/BF00165939 McConkey, 1990, NK cell-induced cytotoxicity is dependent on a Ca2+ increase in the target, FASEB J, 4, 2661, 10.1096/fasebj.4.9.2347464 McGinnis, 1995, Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1, J Neurosci Res, 40, 165, 10.1002/jnr.490400204 Milam, 1993, Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy, Invest Ophthalmol Vis Sci, 34, 91 Milam, 1995, paraneoplastic retinopathy, 461 Mizener, 1997, Autoimmune retinopathy in the absence of cancer, Am J Ophthalmol, 123, 607, 10.1016/S0002-9394(14)71073-6 Murphy, 1996, Paraneoplastic retinopathy, J Neuroophthalmol, 17, 77 Nudelman, 1982, Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2, J Biol Chem, 257, 12752, 10.1016/S0021-9258(18)33576-2 Ohguro, 1999, Recoverin and Hsc 70 are found as autoantigens in patients with cancer- associated retinopathy, Invest Ophthalmol Vis Sci, 40, 82 Ohguro, 1996, Structural and enzymatic aspects of rhodopsin phosphorylation, J Biol Chem, 271, 5215, 10.1074/jbc.271.9.5215 Ohkawa, 1996, Cancer-associated retinopathy in a patient with endometrial cancer, Am J Ophthalmol, 122, 740, 10.1016/S0002-9394(14)70501-X Ohnishi, 1993, Cancer-associated retinopathy with retinal phlebitis, Br J Ophthalmol, 77, 795, 10.1136/bjo.77.12.795 Okel, 1995, An unusual case of melanoma-associated retinopathy, Ocul Immunol Inflamm, 3, 121, 10.3109/09273949509085040 Oohira, 1993, A case of paraneoplastic retinopathy, Jpn J Ophthalmol, 37, 28 Palmer, 1999, Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma, Hum Gene Ther, 10, 1261, 10.1089/10430349950017941 Peek, 1998, Muller cell-specific autoantibodies in a patient with progressive loss of vision, Invest Ophthalmol Vis Sci, 39, 1976 Pillay, 1984, Internuclear ophthalmoplegia and optic neuritis, Neurology, 34, 788, 10.1212/WNL.34.6.788 Polans, 1991, A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy, J Cell Biol, 112, 981, 10.1083/jcb.112.5.981 Polans, 1993, Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy, Invest Ophthalmol Vis Sci, 34, 81 Polans, 1995, Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy, Proc Natl Acad Sci USA, 92, 9176, 10.1073/pnas.92.20.9176 Potter, 1999, Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy, Ophthalmology, 106, 2121, 10.1016/S0161-6420(99)90493-1 Remulla, 1995, Cutaneous melanoma-associated retinopathy with retinal periphlebitis, Arch Ophthalmol, 113, 854, 10.1001/archopht.1995.01100070024015 Richter, 1968, Non-invasive central nervous system disease associated with lymphoid tumors, Johns Hopkins Med J, 122, 271 Ries LAG, Eisner MP, Kosary CL, et al (eds): SEER Cancer Statistics Review, 1973–1999, National Cancer Institute. Bethesda, MD, HYPERLINK http://seer.cancer.gov/csr/1973-1999/ Ripps, 1984, Functional abnormalities in vincristine-induced night blindness, Invest Ophthalmol Vis Sci, 25, 787 Rizzo, 1992, Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome, Ophthalmology, 99, 1286, 10.1016/S0161-6420(92)31806-8 Rougier MB, Hostyn P, Bret-Dibat C, et al: [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case]. J Fr Ophtalmol 18:396–403, 1995 Rudge, 1973, Optic neuritis as a complication of carcinoma of the breast, Proc R Soc Med, 66, 1106 Rush, 1993, Paraneoplastic retinopathy in malignant melanoma, Am J Ophthalmol, 115, 390, 10.1016/S0002-9394(14)73594-9 Salgia, 1998, Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma, Lung Cancer, 22, 149, 10.1016/S0169-5002(98)00062-2 Sawyer, 1976, Blindness caused by photoreceptor degeneration as a remote effect of cancer, Am J Ophthalmol, 81, 606, 10.1016/0002-9394(76)90125-2 Singh, 1995, Melanoma-associated retinopathy, Am J Ophthalmol, 119, 369, 10.1016/S0002-9394(14)71185-7 Sobottka B, Schlote T, Besch D, et al: [Carcinoma-associated retinopathy: a review with clinical examples]. Klin Monatsbl Augenheilkd 216:17–24, 2000 Suzuki, 1996, Cancer-associated retinopathy with presumed vasculitis, Am J Ophthalmol, 122, 125, 10.1016/S0002-9394(14)71979-8 Thambisetty, 2001, Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung, J Neuroophthalmol, 21, 164, 10.1097/00041327-200109000-00002 Thirkill, 2000, Retinal pigment epithelial hypersensitivity, an association with vision loss, Ocul Immunol Inflamm, 8, 25, 10.1076/0927-3948(200003)811-SFT025 Thirkill, 1989, Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells, N Engl J Med, 321, 1589, 10.1056/NEJM198912073212307 Thirkill, 1997, Commonalities and diversity in the immune response of cancer-associated retinopathy (CAR) patients, Invest Ophthalmol Vis Sci, 37, S112 Thirkill, 1993, Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy, Arch Ophthalmol, 111, 931, 10.1001/archopht.1993.01090070049018 Thirkill, 1987, Cancer-associated retinopathy, Arch Ophthalmol, 105, 372, 10.1001/archopht.1987.01060030092033 Thirkill, 1992, The cancer-associated retinopathy antigen is a recoverin-like protein, Invest Ophthalmol Vis Sci, 33, 2768 van der Pol, 1987, A non-metastatic remote effect of lung carcinoma, Doc Ophthalmol, 67, 89, 10.1007/BF00142702 Vaphiades, 2000, Node way out, Surv Ophthalmol, 45, 77, 10.1016/S0039-6257(00)00133-8 Waterston, 1986, Paraneoplastic optic neuritis and external ophthalmoplegia, Aust NZ J Med, 16, 703, 10.1111/j.1445-5994.1986.tb00017.x Weinstein, 1994, Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma, Ophthalmology, 101, 1236, 10.1016/S0161-6420(94)31183-3 Whitcup, 1998, Recoverin-associated retinopathy, Am J Ophthalmol, 126, 230, 10.1016/S0002-9394(98)00149-4 Wolf, 1996, Selective magnocellular damage in melanoma-associated retinopathy, Vision Res, 36, 2369, 10.1016/0042-6989(95)00316-9 Wolf, 1996, Selective damage to either the M or P cell pathway in human retinal disease, Eur J Ophthalmol, 6, 208, 10.1177/112067219600600221 Wyllie, 1992, The apoptosis endonuclease and its regulation, Semin Immunol, 4, 389 Yoon, 1999, An unusual type of cancer-associated retinopathy in a patient with ovarian cancer, Korean J Ophthalmol, 13, 43, 10.3341/kjo.1999.13.1.43 Yu, 2001, CRMP-5 neuronal autoantibody, Ann Neurol, 49, 146, 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E